🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Vaccines & Immunotherapies

Benchmark revenue and EBITDA valuation multiples for public comps like Wantai BioPharm, Merck & Co, Pfizer, GSK and CSL.

Vaccines & Immunotherapies

See analyst estimates and all valuation multiples for Vaccines & Immunotherapies
Company EV EV/Revenue EV/EBITDA
$220B 3.4x 8.1x
$169B 2.7x 7.0x
$130B 2.7x 9.2x
$86.8B 2.1x 6.1x
$83.2B 5.5x 16.4x
$29.2B 4.3x 16.4x
$11.1B 27.4x 84.6x
$8.2B 2.1x 15.1x
$5.5B 12.5x 41.1x
$5.1B 1.8x -3.9x
$4.8B 5.8x 21.8x
$3.7B 6.0x 14.4x
$3.3B 1.1x -0.9x
$2.6B 7.2x 40.2x
$2.5B 62.5x n/a
$2.5B n/a n/a
$2.4B 5.8x 19.1x
$2.3B n/a n/a
$1.8B 4.5x 21.8x
$1.8B 14.1x -19.3x
$1.5B 5.9x -25.8x
$1.4B 1.7x 5.7x
$1.2B n/a n/a
$1.1B n/a n/a
$1.1B n/a n/a
$1.0B 5.4x 7.4x
$956M n/a n/a
$866M n/a n/a
$827M 5.6x 11.8x
$820M 2.8x 18.5x
$675M 2.8x 9.9x
$673M 3.7x n/a
$666M 15.2x n/a
$613M n/a n/a
$605M n/a n/a
$597M 3.2x 49.4x
$592M n/a n/a
$555M n/a n/a
$496M n/a n/a
$493M 82.1x -2.5x
$478M n/a n/a
$475M 68.9x -1.6x
$449M n/a n/a
$395M 7.2x -21.2x
$385M 5.2x -15.1x
$316M 1.9x 9.0x
$305M 77.6x -17.0x
$274M 1.3x -2.3x
$272M 0.4x -2.0x
$261M 3.3x -2.3x
$240M n/a n/a
$238M n/a n/a
$223M n/a n/a
$198M 0.5x 1.6x
$191M n/a n/a
$172M 60.8x n/a
$170M n/a n/a
$155M 35.0x -0.6x
$148M 21.0x -9.7x
$147M 15061.3x n/a
$132M n/a n/a
$127M n/a -3.6x
$122M 197.2x -2.0x
$115M n/a n/a
$113M 5798.3x -0.4x
$107M 1.0x n/a
$106M n/a n/a
$105M n/a n/a
$105M 1.4x 2.7x
$101M 64.5x -1.2x
$100M n/a n/a
$84.4M n/a n/a
$74.9M n/a n/a
$73.4M 2.6x n/a
$70.6M n/a n/a
$69.9M 12501.7x -2.9x
$69.5M n/a n/a
$68.8M 3.7x -2.8x
$49.6M 11.0x n/a
$44.3M 2.1x n/a
$43.8M 5.5x n/a
$43.6M 1.6x n/a
$41.1M n/a n/a
$39.8M n/a n/a
$39.3M 2342.3x n/a
$37.5M 0.3x -1.0x
$29.2M n/a -0.8x
$29.1M n/a n/a
$28.9M n/a -1.3x
$26.7M 30.0x n/a
$25.6M n/a n/a
$16.9M 17.7x n/a
$7.3M 2.0x n/a
$7.2M 1.0x -0.5x
$6.9M n/a n/a
$5.4M 65.5x -0.2x
$2.4M 1.1x -0.0x
-$1.5M n/a 0.0x
-$1.6M -0.1x n/a
-$2.6M n/a n/a
-$2.8M -2.7x n/a
-$5.8M -1.1x 0.5x
-$6.9M -0.1x 0.1x
-$7.4M -0.4x n/a
-$8.2M -0.4x 0.2x
-$8.7M -1.4x n/a
-$9.2M -1.0x 0.8x
-$16.1M -0.1x 0.2x
-$18.4M -19.9x n/a
-$29.5M -0.8x n/a
-$32.0M n/a n/a
-$32.5M -8.1x 0.4x
-$32.7M -32.3x n/a
-$34.2M -0.4x 0.3x
-$37.6M -4.6x 0.8x
-$38.7M -0.3x -1.7x
-$46.4M -2.0x n/a
-$52.6M n/a n/a
-$53.2M -0.9x 0.1x
-$58.6M n/a 0.5x
-$62.2M n/a n/a
-$65.7M -14.3x 0.4x
-$66.6M -6.2x 0.4x
-$69.2M -6.6x n/a
-$72.8M n/a n/a
-$84.0M -0.4x 0.3x
-$84.7M -0.7x n/a
-$88.5M n/a 0.8x
-$89.8M n/a 0.8x
-$92.5M -52.6x 0.7x
-$101M n/a n/a
-$111M -27.4x 0.9x
-$116M n/a n/a
-$117M -664.4x n/a
-$146M -1.0x n/a
-$155M -8.5x 0.7x
-$184M -4307.0x 0.6x
-$197M n/a 1.3x
-$241M -9.0x 1.5x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Vaccines & Immunotherapies

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.